Neurogene (NGNE) Interest Expenses (2013 - 2026)
Neurogene (NGNE) reported Interest Expenses of $9000.0 for Q1 2026, up 350.0% on a YoY basis from $2000.0 in Q1 2025, and up 104.71% quarter-over-quarter from -$191000.0 in Q4 2025.
Neurogene (NGNE) Interest Expenses (2013 - 2026) Analysis & Trends
Neurogene has reported Interest Expenses for 9 years, with the latest figure at $9000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 350.0% year-over-year to $9000.0; the trailing twelve-month figure through Mar 2026 stood at -$66000.0 (down 112.22% YoY), and the FY2025 full-year result was $5000.0, down 58.33% from the prior year.
- Interest Expenses for Q1 2026 stood at $9000.0, up from -$191000.0 in the prior quarter.
- The five-year high for Interest Expenses was $533000.0 in Q2 2024, with the low at -$191000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $38769.2 across 4 years, with a median of $3000.0 in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses soared 17666.67% — and 2025, when it plunged 9650.0%.
- Neurogene's Interest Expenses stood at $17000.0 in 2023, then plunged by 88.24% to $2000.0 in 2024, then sank by 9650.0% to -$191000.0 in 2025, then jumped by 104.71% to $9000.0 in 2026.
- The last three Interest Expenses figures came in at $9000.0 (Q1 2026), -$191000.0 (Q4 2025), and $42000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 533,000.00 |
| Jun 30, 2024 | 533,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |